OpenLegislation

Paragraph 9 I1

England, Wales and Scotland

A liquid formulation—

(a)

containing a botanical extract of cannabis—

(i)

with a concentration of not more than 30 milligrams of cannabidiol per millilitre, and not more than 30 milligrams of delta-9-tetrahydrocannabinol per millilitre, and

(ii)

where the ratio of cannabidiol to delta-9-tetrahydrocannabinol is between 0.7 and 1.3,

(b)

which is dispensed through a metered dose pump as a mucosal mouth spray, and

(c)

which was approved for marketing by the Medicines and Healthcare Products Regulatory Agency on the 16th June 2010.

Annotations

Commencement

I1

Sch. 1 para. 9 in force at 31.5.2015, see art. 1(1)